You searched for T cells - Page 28 of 41

Best in Biotech 20 Feb 2018

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

…of CAR-T cell therapy and T-cell receptor technologies. Both approaches have shown great promise for cancer treatment, with the two first CAR-T therapies launched into the market in 2017. To…

February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 2 May 2017

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

…Celyad’s allogeneic CAR-T therapy. By using T cells derived from a healthy donor, allogeneic CAR-T therapy is thought to be more cost- and time-effective, allowing for off-the-shelf available T cells…

May 2, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 9 Jan 2018

Scancell and BioNTech Will Combine Their Expertise to Fight Cancer

…for the treatment of cancer and it has announced that it will come together with Europe’s largest private biopharma, BioNTech, to develop T-cell receptor (TCR)-based therapies. In particular, the collaboration…

January 9, 2018 - 3 minutesmins - By Alex Dale

News and Trends 29 Sep 2016

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

…are now advancing their programs in CAR-T, the breakthrough therapy that everyone’s after. In this treatment, the patient’s T-cells are engineered in vitro, rewired to attack a specific tumor antigen…

September 29, 2016 - 5 minutesmins - By Clara Rodríguez Fernández

In Depth 15 Feb 2024

Turning the tide: recent advancements in childhood cancer research

…Last year, BrainChild took its CAR-T candidate to the clinic to evaluate four different targets. It plans to create a CAR-T cell therapy platform that can address multiple targets, include…

February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 22 Sep 2022

New study shows how prostate cancer may start

…are primed and ready to develop prostate cancer. This means that it may be better to treat the whole prostate rather than only the areas in the prostate that have…

September 22, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 22 Oct 2024

Eight nanotechnology companies to watch out for

…involves nanoparticles that bind to immune cells. The cells travel to the spleen and liver, where they undergo cell death. Then, the disease-specific antigens present inside the particles are released….

October 22, 2024 - 10 minutesmins - By Roohi Mariam Peter

Startup Scout 31 Jan 2020

This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells

…normally kill tumor cells, so blocking these molecules could let the immune system regain the ability to attack the cancer. A promising class of immunotherapy drugs to treat solid tumors…

January 31, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 12 Mar 2018

A Flick of a Switch Can Cause Age-Related Brain Deterioration

…we will have to hope that biotechs in this area are able to make the most of these findings and bring an effective treatment for devastating diseases like Alzheimer’s to…

March 12, 2018 - 3 minutesmins - By Alex Dale

Immunicum cancer immunotherapy dendritic cell

News and Trends 16 Oct 2018

Cancer Immunotherapy Biotech Raises €34M on Nasdaq Stockholm

…most of the funding to run a Phase Ib/II clinical trial that will test its lead cell therapy candidate in combination with checkpoint inhibitors to treat multiple cancer types. The…

October 16, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 27 Jul 2022

The race to uncloak cancer with liquid biopsies

…work for some but not all, and they’re expensive. “We have to ensure that the right patients receive the right therapy, and the way to do that is via liquid…

July 27, 2022 - 10 minutesmins - By Editorial Team

Podcast 2 Feb 2024

BioSenic showcasing knee osteoarthritis treatment

…to find the best way to inject your product and it was decided to inject directly after the fracture. We found out post hoc that maybe it would have been…

February 2, 2024 - 7 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

Scancell and BioNTech Will Combine Their Expertise to Fight Cancer

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

Turning the tide: recent advancements in childhood cancer research

New study shows how prostate cancer may start

Eight nanotechnology companies to watch out for

This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells

A Flick of a Switch Can Cause Age-Related Brain Deterioration

Cancer Immunotherapy Biotech Raises €34M on Nasdaq Stockholm

The race to uncloak cancer with liquid biopsies

BioSenic showcasing knee osteoarthritis treatment

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!